BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Latest 15-12G SEC Filings
Securities registration termination [Section 12(g)]

DIACRIN INC /DE/, 15-12G, 2001-01-19
BIOMATRIX INC, 15-12G, 2000-12-19
GENZYME CORP, 15-12G, 2000-12-19
LIFE TECHNOLOGIES INC, 15-12G, 2000-09-19
CREATIVE BIOMOLECULES INC, 15-12G, 2000-07-31
ARIAD PHARMACEUTICALS INC, 15-12G, 2000-06-19
LIPOSOME CO INC, 15-12G, 2000-05-12
RIBI IMMUNOCHEM RESEARCH INC, 15-12G, 1999-10-08
SUGEN INC, 15-12G, 1999-09-01
SPARTA PHARMACEUTICALS INC, 15-12G, 1999-08-13
TRANSCEND THERAPEUTICS INC, 15-12G, 1999-06-09
ORAVAX INC /DE/, 15-12G, 1999-05-11
GENEMEDICINE INC, 15-12G, 1999-03-18
ANERGEN INC, 15-12G, 1999-02-11
VIRUS RESEARCH INSTITUTE INC, 15-12G, 1998-08-21
SERAGEN INC, 15-12G, 1998-08-12
SOMATOGEN INC, 15-12G, 1998-05-05
ANTEX BIOLOGICS INC, 15-12G, 1997-12-18
SOMATIX THERAPY CORPORATION, 15-12G, 1997-06-23
DIACRIN INC /DE/, 15-12G, 1997-02-11
GENZYME CORP, 15-12G, 1997-01-17
GENETICS INSTITUTE INC, 15-12G, 1997-01-02
NEOZYME II CORP, 15-12G, 1996-11-08
GENETICS INSTITUTE INC, 15-12G, 1996-06-03
AMGEN INC, 15-12G, 1995-03-30
VIRATEK INC, 15-12G, 1994-11-10


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission